医药工业及其对外经贸是广东经济重要的组成部分，包括医药制造业和医疗器械制造两大部分。通过深入研究，发现广东医药工业有以下特点。一是2000～2019年，广东医药品进出口贸易除了在2010年是顺差外，其余各年皆为逆差，且逆差有扩大趋势。二是广东医疗器械制造比广东医药制造业有更强的出口竞争优势。三是与化学药品原料药制造和化学药品制剂制造的出口相比，广东中药材及中成药出口下降特别严重。四是外资企业对广东医药制造业投资的贡献度自2006年以来不断下降，2010年以后外资企业在广东医药制造业产值和出口中的占比不断下降，竞争力和地位呈弱化趋势。五是受中美贸易摩擦的影响，广东医药品生产企业主要通过降价维持对美出口。六是广东医药工业对外经贸逐步落后于其他的医药制造强省，且差距越来越大。七是广东医药制造业新产品收入中的出口收入占比长期低于全国平均值，也明显低于其他医药制造强省，表明广东医药制造业新产品出口竞争力较弱。最后，本报告依据广东医药工业对外经贸发展过程中表现出的特征事实和薄弱之处，给出了针对性较强的政策建议。
Pharmaceutical industry and its foreign trade is an important part of Guangdong’s economy，including pharmaceutical manufacturing and medical devices manufacturing. Through in-depth study，the following findings on Guangdong’s pharmaceutical industry are obtained. First，from 2000 to 2019，except for the surplus in 2010，the balance of import and export of pharmaceutical products in Guangdong was in deficit in other years，and the deficit has been constantly expanding. Second，Guangdong’s medical devices manufacturing have a stronger export competitive advantage than its pharmaceutical manufacturing. Third，compared with the export of chemical raw materials and chemical preparations，the export of Chinese medicinal materials and proprietary Chinese medicines in Guangdong declined especially seriously. Fourth，since 2010，the proportion of foreign-funded enterprises in the output value and export of Guangdong’s pharmaceutical manufacturing industry has been declining，and the competitiveness and position have been weakened. In addition，the contribution of foreign enterprises to Guangdong’s pharmaceutical manufacturing investment has been declining since 2006. Fifth，under the influence of Sino-US trade friction，Guangdong’s pharmaceutical manufacturers mainly maintain their export to the US by lowering prices. Sixth，pharmaceutical enterprises in Guangdong need to increase investment in research and development in the future，otherwise，the gap with other several pharmaceutical manufacturing strong provinces would get bigger. Seventh，the proportion of export revenue of new pharmaceutical products in Guangdong has been lower than the national average level for a long time，and is also significantly lower than that of other strong pharmaceutical manufacturing provinces，indicating that the export competitiveness of new pharmaceutical products in Guangdong is weak. Finally，based on the characteristics，facts and weaknesses of the foreign economic and trade development of Guangdong’s pharmaceutical industry，this report gives some policy suggestions with strong pertinence.
